Results 151 to 160 of about 1,343 (178)
Cell-Free DNA Fragmentomics: The Novel Promising Biomarker
Cell-free DNA molecules are released into the plasma via apoptotic or necrotic events and active release mechanisms, which carry the genetic and epigenetic information of its origin tissues. However, cfDNA is the mixture of various cell fragments, and the efficient enrichment of cfDNA fragments with diagnostic value remains a great challenge for ...
Qinyu Ge, Min Pan, Yunfei Bai
exaly +4 more sources
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer [PDF]
Identifying novel circulating biomarkers predictive of response and informative about the mechanisms of resistance, is the new challenge for breast cancer (BC) management.
Ugo De Giorgi +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Fragmentomics of Proteins and Natural Oligopeptides
Biophysics, 2008The term fragmentomics is grounded and defined. Theoretical structure-function analysis of all possible fragments of a protein molecule was performed under the concept of fragmentomics to determine the regions that could be potential sources of regulatory oligopeptides.
A A Zamyatnin
exaly +4 more sources
Cell-Free DNA Fragmentomics in Cancer
The analysis of cell-free DNA (cfDNA) fragmentation patterns, known as "fragmentomics," has opened new opportunities in noninvasive cancer diagnostics. Due to its close relationships with genomic organization and cell death, cfDNA fragmentomics lies at the intersection of many aspects of cancer biology, including epigenetic dysregulation ...
Peiyong Jiang +2 more
exaly +3 more sources
Fragmentomics Features of Ovarian Cancer
AbstractOvarian cancer (OC) is a major cause of cancer mortality in women worldwide. Due to the occult onset of OC, its nonspecific clinical symptoms in the early phase, and a lack of effective early diagnostic tools, most OC patients are diagnosed at an advanced stage.
Lei Li, Jing Wang, Huanwen Wu
exaly +3 more sources
Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies
Science, 2021Enhancing liquid biopsies Liquid biopsies, analyses of cell-free DNA that circulates in the blood, can be used in prenatal testing, oncology, and to monitor organ transplant recipients. Lo et al.
Y. M. Dennis Lo +3 more
openaire +2 more sources
Fragmentomic analysis of circulating tumor DNA-targeted cancer panels
Annals of Oncology, 2023The isolation of cell-free DNA (cfDNA) from the bloodstream can be used to detect and analyze somatic alterations in circulating tumor DNA (ctDNA), and multiple cfDNA-targeted sequencing panels are now commercially available for Food and Drug Administration (FDA)-approved biomarker indications to guide treatment.
K T, Helzer +33 more
openaire +2 more sources
Longitudinal Profiling of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer Through Droplet Digital PCR-Based Circulating Tumor DNA Fragmentomics [PDF]
Background: In the context of hormone receptor positive, HER2 negative Metastatic breast cancer (MBC), CDK 4/6 inhibitors (CDK4/6i) combined with endocrine therapy represent the standard first-line treatment, improving Progression-Free Survival (PFS) and
Alessandro Marco Minisini +2 more
exaly +2 more sources

